• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用高效液相色谱法测定沙利度胺及其主要代谢产物。

Determination of thalidomide and its major metabolites by high-performance liquid chromatography.

作者信息

Czejka M J, Koch H P

出版信息

J Chromatogr. 1987 Jan 23;413:181-7. doi: 10.1016/0378-4347(87)80225-6.

DOI:10.1016/0378-4347(87)80225-6
PMID:3558667
Abstract

A rapid and sensitive isocratic high-performance liquid chromatography assay for the simultaneous and quantitative determination of thalidomide (alpha-phthalimidoglutarimide) and its major metabolites from human serum has been developed. The parent compound and the metabolites can be efficiently separated by reversed-phase chromatography using tetramethylammonium bromide as an ion-pair-forming reagent.

摘要

已开发出一种快速灵敏的等度高效液相色谱分析法,用于同时定量测定人血清中的沙利度胺(α-邻苯二甲酰亚胺基戊二酰亚胺)及其主要代谢物。使用溴化四甲基铵作为离子对形成试剂,通过反相色谱法可有效分离母体化合物及其代谢物。

相似文献

1
Determination of thalidomide and its major metabolites by high-performance liquid chromatography.采用高效液相色谱法测定沙利度胺及其主要代谢产物。
J Chromatogr. 1987 Jan 23;413:181-7. doi: 10.1016/0378-4347(87)80225-6.
2
Quantitative determination of thalidomide in human serum with high-performance liquid chromatography using protein precipitation with trichloroacetic acid and ultraviolet detection.
J Chromatogr B Biomed Sci Appl. 1999 Nov 12;734(2):203-10. doi: 10.1016/s0378-4347(99)00345-x.
3
A validated LC-MS/MS method for the simultaneous determination of thalidomide and its two metabolites in human plasma: Application to a pharmacokinetic assay.一种用于同时测定人血浆中沙利度胺及其两种代谢物的经过验证的液相色谱-串联质谱法:应用于药代动力学分析。
Biomed Chromatogr. 2018 Aug;32(8):e4240. doi: 10.1002/bmc.4240. Epub 2018 Apr 19.
4
Determination of the thalidomide analogues 2-(2,6-dioxopiperidine-3-yl)phthalimidine (EM 12), 2-(2,6-dioxopiperidine-4-yl)phthalimidine (EM 16) and their metabolites in biological samples.生物样品中沙利度胺类似物2-(2,6-二氧代哌啶-3-基)邻苯二甲酰亚胺(EM 12)、2-(2,6-二氧代哌啶-4-基)邻苯二甲酰亚胺(EM 16)及其代谢物的测定。
J Chromatogr. 1989 Mar 24;488(2):417-25. doi: 10.1016/s0378-4347(00)82965-5.
5
Determination of thalidomide in plasma and blood by high-performance liquid chromatography: avoiding hydrolytic degradation.
J Chromatogr. 1992 Nov 6;582(1-2):211-6. doi: 10.1016/0378-4347(92)80321-g.
6
Determination of thalidomide by high performance liquid chromatography: methodological strategy for clinical trials.高效液相色谱法测定沙利度胺:临床试验的方法策略
Clin Biochem. 1995 Aug;28(4):467-70. doi: 10.1016/0009-9120(95)00019-6.
7
Determination of thalidomide by high performance liquid chromatography: plasma pharmacokinetic studies in the rat.
J Pharm Biomed Anal. 2005 Sep 1;39(1-2):299-304. doi: 10.1016/j.jpba.2005.02.041. Epub 2005 Apr 25.
8
High-performance liquid chromatographic assay of plasma thalidomide: stabilization of specimens and determination of a tentative therapeutic range for chronic graft-versus-host disease.血浆沙利度胺的高效液相色谱测定:标本的稳定性及慢性移植物抗宿主病暂定治疗范围的测定
Ann Clin Biochem. 1995 Jan;32 ( Pt 1):79-83. doi: 10.1177/000456329503200108.
9
Determination of CC-5013, an analogue of thalidomide, in human plasma by liquid chromatography-mass spectrometry.采用液相色谱-质谱联用技术测定人血浆中沙利度胺类似物CC-5013的含量。
J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Nov 25;811(2):135-41. doi: 10.1016/j.jchromb.2004.08.022.
10
Determination of (4-(1,3-dioxo-1,3-dihydro-2H-isoindol- 2-yl)-N'-[(4-ethoxyphenyl) methylidene] benzohydrazide, a novel anti-inflammatory agent, in biological fluids by UPLC-MS/MS: Assay development, validation and in vitro metabolic stability study.采用超高效液相色谱-串联质谱法测定生物样品中新型抗炎药(4-(1,3-二氧代-1,3-二氢-2H-异吲哚-2-基)-N'-[(4-乙氧基苯基)亚甲基]苯甲酰肼:分析方法的建立、验证及体外代谢稳定性研究
Biomed Chromatogr. 2017 Oct;31(10). doi: 10.1002/bmc.3981. Epub 2017 May 7.

引用本文的文献

1
Identification and removal of a cryptic impurity in pomalidomide-PEG based PROTAC.泊马度胺-聚乙二醇化PROTAC中一种隐匿杂质的鉴定与去除
Beilstein J Org Chem. 2025 Feb 18;21:407-411. doi: 10.3762/bjoc.21.28. eCollection 2025.
2
Thalidomide and discoid lupus erythematosus: case series and review of literature.沙利度胺与盘状红斑狼疮:病例系列及文献综述
Drugs Context. 2022 Mar 16;11. doi: 10.7573/dic.2021-9-8. eCollection 2022.
3
Structural basis of thalidomide enantiomer binding to cereblon.沙利度胺对映异构体与 cereblon 结合的结构基础。
Sci Rep. 2018 Jan 22;8(1):1294. doi: 10.1038/s41598-018-19202-7.
4
Thalidomide in dermatology: revisited.沙利度胺在皮肤病学中的应用:再探讨。
Indian J Dermatol. 2015 Mar-Apr;60(2):213. doi: 10.4103/0019-5154.152580.
5
Thalidomide: rationale for renewed use in immunological disorders.沙利度胺:在免疫性疾病中重新应用的理论依据。
Drug Saf. 1995 Jun;12(6):364-9. doi: 10.2165/00002018-199512060-00002.